Animal results may pave way to treating rare mitochondrial diseases in children

May 19, 2011 in Medical research

A human drug that both prevents and cures kidney failure in mice sheds light on disabling human mitochondrial disorders, and may represent a potential treatment in people with such illnesses.

"There are no effective cures for mitochondrial diseases, even in animals," said study leader Marni J. Falk, M.D., who cares for children in the Mitochondrial-Genetics Disease Clinic at The Children's Hospital of Philadelphia. "So these striking results in mice may suggest a novel therapy of direct relevance for humans."

Falk and colleagues published their study online May 5 in the journal EMBO Molecular Medicine.

Mitochondria are tiny structures that operate as powerhouses within human and animal cells, generating energy from food. As such, they are fundamental to life. Failures of proper impair a wide range of organ systems.

Individually, mitochondrial diseases are very rare. However, because there are hundreds of these disorders, they collectively have a broad impact, affecting at least 1 in 5,000 people, and possibly more. Malfunctioning mitochondria also contribute to complex disorders, including diabetes, epilepsy, Alzheimer's disease and .

The current study focused on an inherited genetic deficiency that prevents the production of coenzyme Q, a critical antioxidant and component of the energy-generating respiratory chain. In humans and in the used to model this disease, the deficiency results in fatal . The current treatment, which consists of providing regular supplements of the missing enzyme product, , is often ineffective.

Falk's team fed the mutant mice probucol, an oral drug formerly used to treat people with (since replaced for that purpose by ). The drug prevented the mice from developing , and also reversed kidney disease in mice that had already developed it. It also raised the levels of coenzyme Q10 within the animals' tissues and corrected signaling abnormalities.

"This drug showed remarkable benefits in the mice, especially when compared to directly feeding the mice supplements of the missing co-factor—coenzyme Q10," said Falk. "If this approach can be safely translated to humans, we may have a more effective treatment for mitochondrial disease than anything currently being used."

Primary coenzyme Q deficiency is vanishingly rare in humans—only a few dozen people are known to have the disease. However, said Falk, the disease is representative of a more common group of inherited, hard-to-treat mitochondrial diseases called respiratory chain (RC) defects.

RC defects share a common cellular failure to properly consume oxygen for the purposes of generating energy. Such defects, caused by a wide range of genetic disorders that affect mitochondria, constitute a common culprit in human mitochondrial disease. "If using probucol or a similar drug can benefit patients with defects in the respiratory chain, this could be a significant advance in treating ," said Falk.

At the very least, added Falk, the current study increases basic understanding of the biology of mitochondrial disease. She noted that continuing research building on her team's findings may set the stage for eventual clinical trials using this approach.

More information: "Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice," EMBO Molecular Medicine, published online May 5, 2011. doi: 10.1002/emmm.201100149

Provided by Children's Hospital of Philadelphia search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Math and dyslexia?
    created17 hours ago
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • A couple of questions about schizophrenia
    createdMay 17, 2012
  • Paralyzed woman uses thoughts to move robotic arm
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Researchers spearhead groundbreaking research into treatment of brain swelling

Researchers at Trinity College Dublin have reported the results of groundbreaking research into the prevention of cerebral oedema or swelling of the brain, a major cause of death in people who have sustained a traumatic injury ...

Medical research created 3 hours ago | popularity not rated yet | comments 0 | with audio podcast

FDA clears test for mastocytosis diagnosis

The Food and Drug Administration has approved a new test to help physicians diagnose a group of rare cell disorders. The test, or assay, was developed by an expert at Virginia Commonwealth University in the field of mast ...

Medical research created 3 hours ago | popularity not rated yet | comments 0

Novel biomarkers reveal evidence of radiation exposure

Researchers at the Medical College of Wisconsin have identified novel biomarkers that could be used to confirm exposure to damaging radiation in large groups of people potentially exposed to unknown and variable doses for ...

Medical research created 3 hours ago | popularity not rated yet | comments 0

Stem cell research paves way for progress on dealing with Fragile X retardation

Researchers at the Hebrew University of Jerusalem have achieved, for the first time, the generation of neuronal cells from stem cells of Fragile X patients. The discovery paves the way for research that will examine restoration ...

Medical research created 5 hours ago | popularity not rated yet | comments 0

Limits to growth: Scientists identify key metastasis-enabling enzyme

(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development ...

Medical research created 7 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast feature


Scientists unravel role of fusion gene in prostate cancer

Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth. Now, Weill ...

Early-life risk factors for non-Hodgkin lymphoma

Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published May 22 in the Journal of ...

Studies examine CPAP treatment and cardiovascular outcomes in adults with obstructive sleep apnea

Two studies that included adults with obstructive sleep apnea examined the effectiveness of reducing the risk of cardiovascular outcomes, including high blood pressure, by treatment with continuous positive airway pressure ...

Systems treating severe heart attacks expanding nationwide

The number of systems of care that quickly transfer and treat heart attack patients has increased substantially across the nation, according to research published in Circulation: Cardiovascular Quality and Outcomes, an American ...

Use of multicomponent intervention linked with decrease in using physical restraint in nursing homes

Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and ...

Body building, diet supplements linked to liver damage: study

(HealthDay) -- Body-building and weight-loss products are the types of dietary supplements most likely to cause liver injury, according to a small new study.